Vazculep
NDC Package 68001-331-65

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Vazculep is a . Marketed by Bluepoint Laboratories, this product is identified by NDC 68001-331 and is authorized under FDA application NDA204300.

Identification & Billing

NDC Package Code
68001-331-65
Package Description
1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON / 10 mL in 1 VIAL, PHARMACY BULK PACKAGE
Product Code
68001-331
11-Digit Billing Format
68001033165

Clinical Specifications

Proprietary Name
Vazculep
Dosage Form
-

Regulatory & Marketing

Labeler Name
Bluepoint Laboratories
FDA Application #
NDA204300
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
06-30-2017
End Marketing Date
03-31-2020
Listing Expiration
03-31-2020
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 68001-331-65 identifies a specific commercial package of 1 vial, pharmacy bulk package in 1 carton / 10 ml in 1 vial, pharmacy bulk package of Vazculep, labeled by Bluepoint Laboratories. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Bluepoint Laboratories on June 30, 2017. The current certification is valid through March 31, 2020.

How is this Bluepoint Laboratories product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 68001033165. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
68001-331-65
11-Digit CMS (5-4-2)
68001-0331-65

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.